Evidence map›Paper›PMID 24454922›Full record

ArticlePloS one2014

Rare variant association testing by adaptive combination of P-values.

Wan-Yu Lin, Xiang-Yang Lou, Guimin Gao, Nianjun Liu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. OPATs: Omnibus P-value association tests.Briefings in bioinformatics · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Wan-Yu LinInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Xiang-Yang LouDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Guimin GaoDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Nianjun LiuDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
University of Alabama at Birmingham · USNational Taiwan University · TWVirginia Commonwealth University · US

Funding

Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
Sex Related Determinants Of Pain In FibromyalgiaP60AR048095 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRIDGES, S LOUIS · 2002 to 2012
$11.7M
Predictors of hemorrhage among patients on direct acting oral anticoagulantsR01HL092173 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIMDI, NITA A · 2008 to 2023
$10.4M
Genome Wide Haplotype Association AnalysisR01GM081488 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIU, NIANJUN · 2008 to 2012
$1.3M
Haplotyping and QTL Mapping in Pedigrees with Missing DataR01GM073766 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI GAO, GUIMIN · 2007 to 2011
$1.3M
NHLBI NIH HHS R01 HL092173NHLBI NIH HHS R01HL092173NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01AR049084NIAMS NIH HHS P60 AR048095NIAMS NIH HHS P60AR048095NIDA NIH HHS R01DA095025NIGMS NIH HHS R01 GM073766NIGMS NIH HHS R01GM073766NIGMS NIH HHS R01 GM081488NIGMS NIH HHS R01GM081488
6 · The paper itself

Abstract

With the development of next-generation sequencing technology, there is a great demand for powerful statistical methods to detect rare variants (minor allele frequencies (MAFs)<1%) associated with diseases. Testing for each variant site individually is known to be underpowered, and therefore many methods have been proposed to test for the association of a group of variants with phenotypes, by pooling signals of the variants in a chromosomal region. However, this pooling strategy inevitably leads to the inclusion of a large proportion of neutral variants, which may compromise the power of association tests. To address this issue, we extend the [Formula: see text]-MidP method (Cheung et al., 2012, Genet Epidemiol 36: 675-685) and propose an approach (named 'adaptive combination of P-values for rare variant association testing', abbreviated as 'ADA') that adaptively combines per-site P-values with the weights based on MAFs. Before combining P-values, we first imposed a truncation threshold upon the per-site P-values, to guard against the noise caused by the inclusion of neutral variants. This ADA method is shown to outperform popular burden tests and non-burden tests under many scenarios. ADA is recommended for next-generation sequencing data analysis where many neutral variants may be included in a functional region.

Indexed as

High-Throughput Nucleotide SequencingSequence Analysis, DNAAlgorithmsCase-Control StudiesComputer SimulationData Interpretation, StatisticalGene FrequencyGenetic Association StudiesHeart DiseasesHumansLinear ModelsModels, GeneticPolymorphism, Single NucleotideSoftware

Identifiers

PMID24454922
PMCPMC3893264
OpenAlexW2165962022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.